‘Undo-Allo’ Stem Cell Transplantation: Another Concept to Control Allogeneic Immunotherapy?

Publisher： Karger

E-ISSN： 1423-0399|72|2|178-

ISSN： 0042-1138

Source： Urologia Internationalis, Vol.72, Iss.2, 2004-02, pp. : 178-

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Is ABO mismatch another risk factor for allogeneic hematopoietic stem cell transplantation in pediatric thalassemic patients?

By  

PEDIATRIC TRANSPLANTATION, Vol. 19, Iss. 6, 2015-09 ,pp. : 645-651

John Wiley & Sons Inc

Access to resources Recommend Favorite

Allogeneic Cell-Mediated Immunotherapy at the Stage of Minimal Residual Disease following High-Dose Chemotherapy Supported by Autologous Stem Cell Transplantation

By  

Acta Haematologica, Vol. 114, Iss. 4, 2005-11 ,pp. : 214-220

Karger

Access to resources Recommend Favorite

Allogeneic Hematopoietic Cell Transplantation as Consolidation Immunotherapy of Cancer after Autologous Transplantation

By  

Acta Haematologica, Vol. 114, Iss. 4, 2005-11 ,pp. : 221-229

Karger

Access to resources Recommend Favorite

ABO-Mismatched Allogeneic Hematopoietic Stem Cell Transplantation

By  

Transfusion Medicine and Hemotherapy, Vol. 43, Iss. 1, 2016-0 ,pp. : 3-12

Karger

Access to resources Recommend Favorite

Azacitidine and Allogeneic Stem Cell Transplantation: When and Why?

By  

Acta Haematologica, Vol. 134, Iss. 1, 2015-06 ,pp. : 38-39

Karger

Access to resources Recommend Favorite